Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses

Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses

Abstract Background Shorter duration of symptoms before remdesivir has been associated with better outcomes. Our goal was to evaluate variables associated with the need of ICU admission in a cohort of hospitalized patients for COVID-19 under remdesivir including the period from symptoms onset to rem...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Rodrigo Alonso-Navarro, Margarita Ramírez, Mar Masiá, Roger Paredes, Rocío Montejano, Marina Povar-Echeverria, Jordi Carratalà, Miguel Salavert, Enrique Bernal, Carlos Dueñas, Juan Flores, Francisco Fanjul, Isabel Gutiérrez, Verónica Rico, Lourdes Mateu, Julen Cadiñanos, Juan Berenguer, Alex Soriano
Формат: Өгүүллэг
Хэл сонгох:English
Хэвлэсэн: BMC 2023-05-01
Цуврал:BMC Infectious Diseases
Нөхцлүүд:
SARS-CoV-2
Remdesivir
Days from symptoms onset
ICU
Progression
Онлайн хандалт:https://doi.org/10.1186/s12879-023-08222-y

Интернэт

https://doi.org/10.1186/s12879-023-08222-y

Ижил төстэй зүйлс